查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600165

非侵入性產前檢測市場：按產品、方法、測試類型、應用和最終用戶 - 2025-2030 年全球預測

Non-invasive Prenatal Testing Market by Product (Consumables, Instruments), Method (Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Fetal Cells in Maternal Blood Tests), Test Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年非侵入性產前檢測市值為74億美元，預計2024年將達78億美元，複合年成長率為5.47%，到2030年將達到107.5億美元。

非侵入性產前檢測 (NIPT) 包括最先進的產前篩檢方法，利用孕婦血液中循環的遊離胎兒 DNA 來檢測唐氏症、愛德華茲症候群和帕陶氏症等疾病，評估您患有某有些遺傳疾病的風險。 NIPT 的需求在於，與羊膜穿刺術等侵入性方法相比，它能夠以最小的風險提供高精度。 NIPT的應用範圍不僅限於染色體異常篩檢，還可能擴展到單染色體異常和產前性別測定。典型的最終用戶包括醫院、診斷實驗室和產科專科診所。市場成長的主要驅動力是母親年齡的增加、基因檢測意識的提高以及基因組學技術的進步。

主要市場統計
基準年[2023] 74億美元
預測年份 [2024] 78億美元
預測年份 [2030] 107.5億美元
複合年成長率（%） 5.47%

潛在的成長機會存在於新興市場，這些市場醫療保健服務的可用性和意識的提高正在增加 NIPT 的採用。此外，公司和醫療保健提供者之間的夥伴關係有可能擴大 NIPT 的覆蓋範圍。主要建議包括專注於降低成本以提高可及性，特別是在發展中地區，以及開發全面的測試，以更快、更廣泛地了解產前健康狀況。然而，諸如高成本、道德考慮以及需要熟練人員進行測試和提供諮詢等挑戰正在阻礙市場擴張。道德和解釋問題方面的權衡以及報銷問題也構成了主要障礙。

提高測試特異性和靈敏度、將人工智慧應用於資料分析以及擴展測試參數以包含更多疾病狀態等領域的創新和研究將是有益的。了解市場的高度競爭性質至關重要，許多公司都專注於技術進步和策略聯盟。專注於研發和強力的行銷策略的公司也許能夠透過利用市場動態和解決產前護理方面未滿足的需求來實現持續成長。

市場動態：快速發展的非侵入性產前檢測市場的關鍵市場洞察

非侵入性產前檢測市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 隨著母親年齡的增加，染色體異常的發生率增加
    • 相對於侵入性方法，人們越來越偏好無創技術
    • 提高孕婦對 NIPT 的好處和可用性的認知
  • 市場限制因素
    • 醫療基礎設施不足，農村和人口稀少地區獲得先進醫療技術的機會有限。
  • 市場機會
    • 透過提供全面的測試前和測試後諮詢服務來改善患者體驗和接受度
    • 安全可靠的家用檢測套組的開發和核准
  • 市場挑戰
    • 測試結果的可靠性，尤其是肥胖女性

波特五力：駕馭無創產前檢測市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對非侵入性產前檢測市場的影響

外部宏觀環境因素在塑造非侵入性產前檢測市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解非侵入性產前檢測市場的競爭格局

對非侵入性產前檢測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣非侵入性產前檢測市場供應商的績效評估

FPNV定位矩陣是評估非侵入性產前檢測市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了無創產前檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對無創產前檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著母親年齡的成長，染色體異常的發生率增加
      • 無創技術
      • 提高孕婦對 NIPT 的好處和可用性的認知
    • 抑制因素
      • 農村和發展中地區的醫療基礎設施不足，獲得先進醫療技術的機會有限。
    • 機會
      • 提供全面的測試前和測試後諮詢服務，以增強患者的體驗和理解
      • 安全可靠的家庭檢測套組的開發和核准
    • 任務
      • 測試結果的可靠性，特別是對於肥胖女性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 非侵入性產前檢測市場：依產品

  • 消耗品
    • 檢測套件和試劑
    • 一次性的
  • 裝置
    • 微陣列
    • 次世代定序系統
    • 聚合酵素鏈鎖反應裝置
    • 超音波設備

第7章 非侵入性產前檢測市場：依方法分類

  • 生化篩檢試驗
  • 母體血漿檢測中的遊離 DNA
  • 母體血液檢查中的胎兒細胞
  • 超音波檢測

第8章按測試類型分類的非侵入性產前檢測市場

  • 和諧測試
  • MaterniT21 Plus 測試
  • 全景測試
  • 檢驗測試

第9章 非侵入性產前檢測市場：依應用分類

  • 唐氏症（21 三體）
  • 愛德華茲氏症候群（18 三體）
  • 微缺失症候群
  • 巴陶氏症（13 三體）
  • 性染色體異常

第10章無創產前檢測市場：依最終用戶分類

  • 診斷實驗室
  • 醫院
  • 調查機構
  • 專科診所

第11章 美洲非侵入性產前檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太無創產前檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東和非洲無創產前檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Natera 推出基於 cfDNA 的胎兒 RhD 檢測，以對抗 RhIg 缺乏症，確保 100% 的敏感性、99% 的特異性和最佳化的患者照護。
    • BillionToOne 推出 BabyPeek，一種非侵入性產前基因測試，擴大市場範圍和消費者選擇，同時提供對胎兒特徵的有趣見解。
    • Natera, Inc. 收購 Invitae 資產以加強非侵入性產前檢測產品
  • 戰略分析和建議
    • 納特拉有限公司

公司名單

  • Agilent Technologies, Inc.
  • Berry Genomics Co. Ltd.
  • BGI Group
  • BillionToOne, Inc.
  • Biora Therapeutics, Inc.
  • BioReference Laboratories, Inc.
  • Centogene NV
  • Eurofins LifeCodexx AG by Eurofins Scientific
  • F.Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • Igenomix
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Lilac Insights Pvt. Ltd.
  • MedGenome Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Ravgen Inc.
  • Sonic Healthcare Limited
  • Thermo Fisher Scientific Inc.
  • Yourgene Health by Novacyt UK Holdings Limited
Product Code: MRR-036C5CF3B521

The Non-invasive Prenatal Testing Market was valued at USD 7.40 billion in 2023, expected to reach USD 7.80 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 10.75 billion by 2030.

Non-invasive Prenatal Testing (NIPT) encompasses a cutting-edge approach in prenatal screening, leveraging cell-free fetal DNA circulating in a pregnant woman's blood to assess the risk of certain genetic conditions, such as Down syndrome, Edwards syndrome, and Patau syndrome. The necessity of NIPT lies in its ability to offer high accuracy with minimal risk compared to invasive methods like amniocentesis. Its applications extend beyond screening for chromosomal abnormalities to potentially include monogenic disorders and prenatal sex determination. Key end-users include hospitals, diagnostic labs, and specialized maternity clinics. The market growth is primarily driven by increasing maternal age, growing awareness about genetic testing, and technological advancements in genomics.

KEY MARKET STATISTICS
Base Year [2023] USD 7.40 billion
Estimated Year [2024] USD 7.80 billion
Forecast Year [2030] USD 10.75 billion
CAGR (%) 5.47%

Potential growth opportunities are found in emerging markets, where the adoption of NIPT is rising due to the increasing availability of healthcare services and awareness. Moreover, partnerships between companies and healthcare providers can expand the reach of NIPT. Key recommendations include focusing on reducing costs to enhance accessibility, especially in developing regions, and developing comprehensive tests that provide faster and broader insights into prenatal health. However, challenges such as high costs, ethical considerations, and the need for skilled personnel for test administration and counseling restrain the market expansion. Trade-offs related to ethical and interpretational challenges, along with reimbursement issues, also pose significant hurdles.

Innovation and research in areas like improving the specificity and sensitivity of tests, applying artificial intelligence for data analysis, and expanding test parameters to include more conditions could be beneficial. Understanding the nature of the market, which is increasingly competitive with numerous players focusing on technological advancements and strategic collaborations, is paramount. Companies that emphasize research and development, coupled with robust marketing strategies, have the potential to capitalize on the market dynamics and cater to the unmet needs in prenatal care, positioning themselves for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Non-invasive Prenatal Testing Market

The Non-invasive Prenatal Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of chromosomal abnormalities with increasing maternal age
    • Growing preference for non-invasive techniques over invasive methods
    • Increased awareness among pregnant women about the benefits and availability of NIPT
  • Market Restraints
    • Inadequate healthcare infrastructure and limited access to advanced medical technologies in rural or underdeveloped areas
  • Market Opportunities
    • Providing comprehensive pre-test and post-test counseling services to enhance patient experience and uptake
    • Development and approval of secure and reliable home-testing kits
  • Market Challenges
    • Reliability of test results, especially in obese women

Porter's Five Forces: A Strategic Tool for Navigating the Non-invasive Prenatal Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Non-invasive Prenatal Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Non-invasive Prenatal Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Non-invasive Prenatal Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Non-invasive Prenatal Testing Market

A detailed market share analysis in the Non-invasive Prenatal Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Non-invasive Prenatal Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Non-invasive Prenatal Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Non-invasive Prenatal Testing Market

A strategic analysis of the Non-invasive Prenatal Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-invasive Prenatal Testing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Berry Genomics Co. Ltd., BGI Group, BillionToOne, Inc., Biora Therapeutics, Inc., BioReference Laboratories, Inc., Centogene N.V., Eurofins LifeCodexx AG by Eurofins Scientific, F.Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., Igenomix, Illumina, Inc., Laboratory Corporation of America Holdings, Lilac Insights Pvt. Ltd., MedGenome Inc., Myriad Genetics, Inc., Natera, Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, Ravgen Inc., Sonic Healthcare Limited, Thermo Fisher Scientific Inc., and Yourgene Health by Novacyt UK Holdings Limited.

Market Segmentation & Coverage

This research report categorizes the Non-invasive Prenatal Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Assay Kits & Reagents and Disposables. The Instruments is further studied across Microarrays, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, and Ultrasound Devices.
  • Based on Method, market is studied across Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Fetal Cells in Maternal Blood Tests, and Ultrasound Detection.
  • Based on Test Type, market is studied across Harmony Test, MaterniT21 Plus Test, Panorama Test, and Verifi Test.
  • Based on Application, market is studied across Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), Microdeletion Syndrome, Patau Syndrome (Trisomy 13), and Sex Chromosome Disorders.
  • Based on End User, market is studied across Diagnostic Laboratories, Hospitals, Research Institutes, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chromosomal abnormalities with increasing maternal age
      • 5.1.1.2. Growing preference for non-invasive techniques over invasive methods
      • 5.1.1.3. Increased awareness among pregnant women about the benefits and availability of NIPT
    • 5.1.2. Restraints
      • 5.1.2.1. Inadequate healthcare infrastructure and limited access to advanced medical technologies in rural or underdeveloped areas
    • 5.1.3. Opportunities
      • 5.1.3.1. Providing comprehensive pre-test and post-test counseling services to enhance patient experience and uptake
      • 5.1.3.2. Development and approval of secure and reliable home-testing kits
    • 5.1.4. Challenges
      • 5.1.4.1. Reliability of test results, especially in obese women
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Non-invasive Prenatal Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Assay Kits & Reagents
    • 6.2.2. Disposables
  • 6.3. Instruments
    • 6.3.1. Microarrays
    • 6.3.2. Next-Generation Sequencing Systems
    • 6.3.3. Polymerase Chain Reaction Instruments
    • 6.3.4. Ultrasound Devices

7. Non-invasive Prenatal Testing Market, by Method

  • 7.1. Introduction
  • 7.2. Biochemical Screening Tests
  • 7.3. Cell-free DNA in Maternal Plasma Tests
  • 7.4. Fetal Cells in Maternal Blood Tests
  • 7.5. Ultrasound Detection

8. Non-invasive Prenatal Testing Market, by Test Type

  • 8.1. Introduction
  • 8.2. Harmony Test
  • 8.3. MaterniT21 Plus Test
  • 8.4. Panorama Test
  • 8.5. Verifi Test

9. Non-invasive Prenatal Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Down Syndrome (Trisomy 21)
  • 9.3. Edwards Syndrome (Trisomy 18)
  • 9.4. Microdeletion Syndrome
  • 9.5. Patau Syndrome (Trisomy 13)
  • 9.6. Sex Chromosome Disorders

10. Non-invasive Prenatal Testing Market, by End User

  • 10.1. Introduction
  • 10.2. Diagnostic Laboratories
  • 10.3. Hospitals
  • 10.4. Research Institutes
  • 10.5. Specialty Clinics

11. Americas Non-invasive Prenatal Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Non-invasive Prenatal Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Non-invasive Prenatal Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Natera launches cfDNA-based fetal RhD test to combat RhIg shortage, ensuring 100% sensitivity, 99% specificity, and optimized patient care
    • 14.3.2. BillionToOne launches BabyPeek, a non-invasive prenatal genetic test , expanding market reach and consumer choices while offering fun insights into unborn baby traits
    • 14.3.3. Natera, Inc. acquires Invitae assets to enhance non-invasive prenatal testing offerings
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Natera, Inc.

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Berry Genomics Co. Ltd.
  • 3. BGI Group
  • 4. BillionToOne, Inc.
  • 5. Biora Therapeutics, Inc.
  • 6. BioReference Laboratories, Inc.
  • 7. Centogene N.V.
  • 8. Eurofins LifeCodexx AG by Eurofins Scientific
  • 9. F.Hoffmann-La Roche Ltd.
  • 10. GE HealthCare Technologies Inc.
  • 11. Igenomix
  • 12. Illumina, Inc.
  • 13. Laboratory Corporation of America Holdings
  • 14. Lilac Insights Pvt. Ltd.
  • 15. MedGenome Inc.
  • 16. Myriad Genetics, Inc.
  • 17. Natera, Inc.
  • 18. PerkinElmer Inc.
  • 19. Quest Diagnostics Incorporated
  • 20. Ravgen Inc.
  • 21. Sonic Healthcare Limited
  • 22. Thermo Fisher Scientific Inc.
  • 23. Yourgene Health by Novacyt UK Holdings Limited

LIST OF FIGURES

  • FIGURE 1. NON-INVASIVE PRENATAL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. NON-INVASIVE PRENATAL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NON-INVASIVE PRENATAL TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ASSAY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY FETAL CELLS IN MATERNAL BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HARMONY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MATERNIT21 PLUS TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PANORAMA TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY VERIFI TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DOWN SYNDROME (TRISOMY 21), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY EDWARDS SYNDROME (TRISOMY 18), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PATAU SYNDROME (TRISOMY 13), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET S